377 related articles for article (PubMed ID: 12919759)
1. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
[TBL] [Abstract][Full Text] [Related]
2. A prospective clinical trial to evaluate the microbial barrier of a needleless connector.
Casey AL; Burnell S; Whinn H; Worthington T; Faroqui MH; Elliott TS
J Hosp Infect; 2007 Mar; 65(3):212-8. PubMed ID: 17241691
[TBL] [Abstract][Full Text] [Related]
3. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors.
Menyhay SZ; Maki DG
Am J Infect Control; 2008 Dec; 36(10):S174.e1-5. PubMed ID: 19084153
[TBL] [Abstract][Full Text] [Related]
4. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.
Langgartner J; Linde HJ; Lehn N; Reng M; Schölmerich J; Glück T
Intensive Care Med; 2004 Jun; 30(6):1081-8. PubMed ID: 15085323
[TBL] [Abstract][Full Text] [Related]
5. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap.
Menyhay SZ; Maki DG
Infect Control Hosp Epidemiol; 2006 Jan; 27(1):23-7. PubMed ID: 16418982
[TBL] [Abstract][Full Text] [Related]
6. Chlorhexidine plus alcohol versus povidone iodine plus alcohol, combined or not with innovative devices, for prevention of short-term peripheral venous catheter infection and failure (CLEAN 3 study): an investigator-initiated, open-label, single centre, randomised-controlled, two-by-two factorial trial.
Guenezan J; Marjanovic N; Drugeon B; Neill RO; Liuu E; Roblot F; Palazzo P; Bironneau V; Prevost F; Paul J; Pichon M; Boisson M; Frasca D; Mimoz O;
Lancet Infect Dis; 2021 Jul; 21(7):1038-1048. PubMed ID: 33539734
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
8. An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters.
Mazher MA; Kallen A; Edwards JR; Donlan RM
Lett Appl Microbiol; 2013 Oct; 57(4):282-7. PubMed ID: 23710651
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
10. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity.
Hong H; Morrow DF; Sandora TJ; Priebe GP
Am J Infect Control; 2013 Aug; 41(8):e77-9. PubMed ID: 23394859
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of adding 2% (w/v) chlorhexidine gluconate to 70% (v/v) isopropyl alcohol for skin disinfection prior to peripheral venous cannulation.
Small H; Adams D; Casey AL; Crosby CT; Lambert PA; Elliott T
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):963-5. PubMed ID: 18771405
[TBL] [Abstract][Full Text] [Related]
12. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies.
Safdar N; Kluger DM; Maki DG
Medicine (Baltimore); 2002 Nov; 81(6):466-79. PubMed ID: 12441903
[TBL] [Abstract][Full Text] [Related]
13. Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use.
Casey AL; Karpanen TJ; Nightingale P; Cook M; Elliott TS
J Hosp Infect; 2012 Apr; 80(4):299-303. PubMed ID: 22341495
[TBL] [Abstract][Full Text] [Related]
14. Skin antiseptics used prior to intravascular catheter insertion.
Adams D; Elliot TS
Br J Nurs; 2007 Mar 8-21; 16(5):278-80. PubMed ID: 17505372
[TBL] [Abstract][Full Text] [Related]
15. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
[TBL] [Abstract][Full Text] [Related]
16. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand.
Balamongkhon B; Thamlikitkul V
Am J Infect Control; 2007 Nov; 35(9):585-8. PubMed ID: 17980236
[TBL] [Abstract][Full Text] [Related]
17. A prospective clinical study to investigate the microbial contamination ofa needleless connector.
Seymour VM; Dhallu TS; Moss HA; Tebbs SE; Elliot TS
J Hosp Infect; 2000 Jun; 45(2):165-8. PubMed ID: 10860694
[TBL] [Abstract][Full Text] [Related]
18. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
20. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
